For each trial, the test templates were drawn at random from the library (with a uniform distribution) and centered at the arrival times generated by the Poisson process above to form a train of test templates.
Single-trial template-based classifier results further validate this finding: information from each subband can be used to classify individual sentences, and classifier results that utilize the combination of frequency bands provide better results than single bands alone.
A second challenge overall is the design of a study for a novel compound that is not considered a "mood stabilizer" where the trial design template has conventionally been designed for atypical antipsychotic mood stabilizers (i.e., lurasidone, olanzapine/fluoxetine, and quetiapine).
The authors go on to discuss the results of trials in interstitial lung disease, which underscore the need for a definitive trial design template for studies in this patient population.
Results of trials in ILD have highlighted the need for a definitive trial design template for studies in this patient population, and it is becoming increasingly clear that, in a disease such as SSc, the greatest chance of demonstrating a disease-modifying effect is to target the pathogenesis of the disease.
While the premature closure and small sample size precluded definitive conclusions regarding treatment efficacy, this trial furnishes a template for design and implementation considerations that should improve future SCD analgesic trials.
But some researchers say that a 'cut-and-paste' mentality has increased clinical-trial requirements over time, as scientists have used previous trial protocols as templates for their next studies.
The decoder then made time-predictions by comparing individual prvs from a non-overlapping test trial set to the template prvs.
Because it is sometimes very difficult to determine which atoms in the catalytic site should be included in the templates, even experts on enzyme structure and function might have to create the best template through trial and error.
Anacetrapib, a CETP inhibitor (IC50 = 13 nM) that recently proceeded to phase III clinical trials, was selected as template for ligand-based pharmacophore elucidation [8].
